Accustem Sciences (ACUT) Prepaid Assets (2022 - 2026)
Accustem Sciences (ACUT) posted quarterly Prepaid Assets of $37325.0 for Q1 2026, down 97.51% year-over-year from $1.5 million in Q1 2025, and up 5.09% quarter-over-quarter from $35517.0 in Q4 2025.
Accustem Sciences (ACUT) Prepaid Assets (2022 - 2026) Analysis & Trends
Accustem Sciences (ACUT) has reported Prepaid Assets for 5 consecutive years, with $37325.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 97.51% year-over-year to $37325.0; the TTM figure through Mar 2026 stood at $37325.0 (down 97.51% YoY), while the FY2025 annual figure was $35517.0, down 21.75% from the prior year.
- Prepaid Assets grew to $37325.0 in Q1 2026 per ACUT's latest filing, from $35517.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.5 million in Q1 2025 and bottomed at $35517.0 in Q4 2025.
- Historically, Prepaid Assets has averaged $307454.2 across 5 years, with a median of $99861.5 in 2023.
- Annual changes were most pronounced in 2025 — Prepaid Assets soared 3803.4% — and 2026, when it sank 97.51%.
- Accustem Sciences' Prepaid Assets stood at $168430.0 in 2022, then sank by 35.66% to $108368.0 in 2023, then plunged by 58.12% to $45387.0 in 2024, then retreated by 21.75% to $35517.0 in 2025, then grew by 5.09% to $37325.0 in 2026.
- Business Quant data shows ACUT's Prepaid Assets at $37325.0 in Q1 2026, $35517.0 in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Accustem Sciences | 2.57 Mn | 2.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,325.00 |
| Dec 31, 2025 | 35,517.00 |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 82,196.00 |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 45,387.00 |
| Sep 30, 2024 | 65,414.00 |
| Jun 30, 2024 | 91,355.00 |
| Mar 31, 2024 | 38,428.00 |
| Dec 31, 2023 | 108,368.00 |
| Sep 30, 2023 | 181,610.00 |
| Jun 30, 2023 | 332,016.00 |
| Mar 31, 2023 | 60,154.00 |
| Dec 31, 2022 | 168,430.00 |
| Sep 30, 2022 | 282,113.00 |
| Jun 30, 2022 | 390,954.00 |